Escolar Documentos
Profissional Documentos
Cultura Documentos
Sutphen
203 River Edge Drive
Point Pleasant, NJ 08742
908.770.9026
jsf04292@westpost.net
Executive Summary:
Multiple years of project management and operational management have
molded me into a strong leader of departments and teams. With
experience in both CRO and pharmaceutical/biotech worlds I have
developed strong negotiations skills and am well versed in managing
the CRO/Sponsor relationship and the inherent difficulties that evolve
around time, quality and costs. I have been the first US employee in a
French-based company and have led a small clinical team to facilitate
completion of several large clinical studies. I have successfully
directed organizational changes that were not always popular. In a
nutshell - I get the job done.
Experience:
NicOx Sophia Antipolis, France
Director, US Clinical Operations 2007 to 2010
Overall responsibility for clinical operations in the United States
including, but not limited to Clinical Project Management for US
portions of one global Phase 3 clinical study and for 6 Phase 1 to 3
stand-alone US clinical studies
Participated in development of all RFPs and Task Orders for clinical
projects conducted globally or stand-alone US. Assisted legal
department with negotiation and finalization of 2 Master Service
Agreements
Managed CROs/CRAs/CPMs adherence to agreed recruitment plan,
timetables, budget and quality specifications, ensuring overall
quality performance of the CRO and study sites. Acted as Clinical
Project Manager on 2 clinical studies when necessary due to corporate
needs
Produced quarterly and annual safety reports for multiple INDs and
NDAs and distribute internally and to the Food and Drug Administration
(FDA)
Worked with the clinical study teams to maintain current and
accurate database of AEs
Clinical Research Associate
(1992 to 1994)
In-house Site Management; Monitoring
Responsible for monitoring and managing clinical trials
Conducted prestudy, initiation, routine monitoring, and close-out
visits in Phase II and III studies
Developed CRFs and supervised production and distribution
Coordinated use of central laboratory and centralized EKGs
Negotiated bids from CROs for takeover of clinical study
Managed involvement of CRO for Phase II study
Served as Lead CRA by coordinating input of six CRAs who monitored
and managed sites in Phase III study
Tracked SAEs and follow-up information
Updated and revised the Investigator's Brochure on a quarterly basis
Compiled and produced the FDA IND Annual Report on an
investigational compound
Assisted in training of new Clinical Research Assistants